Q2 2026 Holdings
Filed 2026-08-12 | 40 holdings | $461.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $41.8M | 726,115 | 9.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $27.9M | 217,008 | 6.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $27.6M | 352,437 | 6.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $24.2M | 1,004,215 | 5.2% |
| Incyte Corp(INCY) | COM | 45337C102 | $19.4M | 170,753 | 4.2% |
| Elevance Health Inc Formerly(ELV) | COM | 036752103 | $17.2M | 44,499 | 3.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $16.9M | 294,918 | 3.7% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $16.8M | 33,584 | 3.7% |
| CVS Health Corp(CVS) | COM | 126650100 | $16.1M | 155,337 | 3.5% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $15.1M | 77,944 | 3.3% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $15.0M | 189,468 | 3.3% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $14.1M | 93,168 | 3.1% |
| Abbott Labs(ABT) | COM | 002824100 | $13.4M | 147,444 | 2.9% |
| GE Healthcare Technologies I(GEHC) | COMMON STOCK | 36266G107 | $13.3M | 207,863 | 2.9% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $12.3M | 142,307 | 2.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $11.7M | 54,163 | 2.5% |
| Qiagen NV | ORD SHARES | N72482156 | $11.2M | 287,640 | 2.4% |
| Centene Corp del(CNC) | COM | 15135B101 | $10.4M | 162,405 | 2.3% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $9.8M | 15,780 | 2.1% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $9.8M | 33,350 | 2.1% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $9.7M | 40,689 | 2.1% |
| Amgen Inc(AMGN) | COM | 031162100 | $9.5M | 26,281 | 2.1% |
| Bruker Corp(BRKR) | COM | 116794108 | $9.2M | 152,352 | 2.0% |
| Avantor Inc(AVTR) | COM | 05352A100 | $9.0M | 906,088 | 1.9% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $8.2M | 100,000 | 1.8% |
| Labcorp Holdings Inc(LH) | COM SHS | 504922105 | $7.3M | 26,019 | 1.6% |
| Dexcom Inc(DXCM) | COM | 252131107 | $6.9M | 102,122 | 1.5% |
| Ascendis Pharma A/S(ASND) | ORD SHS | K08588103 | $5.7M | 21,305 | 1.2% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $5.5M | 60,402 | 1.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $5.3M | 241,739 | 1.1% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $5.2M | 121,128 | 1.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $4.8M | 433,012 | 1.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $4.5M | 80,000 | 1.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $4.3M | 114,628 | 0.9% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $4.0M | 267,091 | 0.9% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $4.0M | 968,466 | 0.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $3.8M | 45,000 | 0.8% |
| Organon & Co(OGN) | COMMON STOCK | 68622V106 | $3.7M | 270,781 | 0.8% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $3.5M | 686,844 | 0.8% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $3.1M | 185,177 | 0.7% |